Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage?
American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e46-e52
DOI: 10.1055/a-1827-6712 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Daisy Leon-Martinez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: 17 alpha-Hydroxyprogesterone Caproate, Gestational Age. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Objective
Progesterone administration has been associated with improved neurological outcomes following traumatic brain injury in adults. However, studies examining the effect of progesterone on the risk of neonatal intraventricular hemorrhage (IVH) are inconsistent. We sought to determine if maternal administration of intramuscular 17-α-hydroxyprogesterone caproate (17-OHPC) is associated with decreased rates of IVH in infants born before 32-weeks gestation. Study Design This is a retrospective study of liveborn singleton deliveries between 20- and 32-weeks gestation at two large academic medical centers from January 1, 2012 to August 30, 2020. Data were extracted from hospital electronic medical record data warehouses using standardized definitions and billing and diagnosis codes. We evaluated receipt of 17-OHPC in the antepartum period and diagnosis of IVH (grade I-IV, per Volpe classification) during the neonatal delivery hospitalization encounter. Bivariate and multivariate analyses were performed to examine the association between 17-OHPC and neonatal IVH adjusting for potential confounders. Odds ratio (ORs) and 95% confidence intervals (CIs) were presented.
Results
Among 749 neonates born between 20- and 32-week gestation, 140 (18.7%) of their mothers had received antenatal 17-OHPC and 148 (19.8%) were diagnosed with IVH after birth. No significant association was observed between maternal 17-OHPC and neonatal IVH in unadjusted (OR 1.14, 95% CI 0.72–1.78) or adjusted analyses (adjusted odds ratio 1.14, 95% CI 0.71–1.84). Independent of exposure to 17-OHPC, as expected, infants born
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut.
- Department of Obstetrics and Gynecology, Christiana Care Health System, Newark, Delaware.
ORCID-Profile: Daisy Leon-Martinez, Matthew K Hoffman
Zitieren
APA
Leon-Martinez, D., Bank, T. C., Lundsberg, L. S., Culhane, J., Silasi, M., Son, M., Partridge, C., Reddy, U. M., Hoffman, M. K., & Merriam, A. A. (2024). Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage?. American Journal of Perinatology, 41(S 01 S 01), e46-e52. https://doi.org/10.1055/a-1827-6712
Vancouver
Leon-Martinez D, Bank TC, Lundsberg LS, Culhane J, Silasi M, Son M, et al. Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage?. American Journal of Perinatology. 2024;41(S 01 S 01):e46-e52. doi:10.1055/a-1827-6712
BibTeX
@article{LeonMartinez2024,
author = {Leon-Martinez, Daisy and Bank, Tracy C and Lundsberg, Lisbet S and Culhane, Jennifer and Silasi, Michelle and Son, Moeun and Partridge, Caitlin and Reddy, Uma M and Hoffman, Matthew K and Merriam, Audrey A},
title = {Does Antenatal Progesterone Administration Modify the Risk of Neonatal Intraventricular Hemorrhage?},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {S 01 S 01},
pages = {e46--e52},
doi = {10.1055/a-1827-6712}
}
EUVIMED